| Name | Title | Contact Details |
|---|
Wellframe helps healthcare organizations support people beyond the four walls of care delivery. We provide care transformation services, a patented engagement platform, clinical programs that support the clinical and social determinants of health, and rigorous measurement.
Alliance Homecare is a private home healthcare company offering an extensive range of services, including Private Duty Nursing, Home Health Aides, and Geriatric Care Management. As a Licensed Home Care Services Agency (LHCSA), we cater to a sophisticated client base in the New York metropolitan area. We staff only the highest quality Registered Nurses, Home Health Aides, and healthcare professionals. These individuals understand that our clients expect the very best talent in home care. Our company is committed to providing world class care to our patients and their loved ones while honoring a strict code of confidentiality. We offer an elite and highly qualified team of healthcare professionals who uphold the strongest principles of integrity and professionalism. The company was founded in 2006 by Gregory Solometo and two childhood friends who are both Registered Nurses. Gregory wanted to take a different approach to home care after he discovered how difficult it was to find quality caregivers to look after his grandmother with Alzheimer`s. During her five-year journey with the disease, Gregory encountered firsthand the challenges and costs of caring for an elderly family member, both in the home and in a facility. Now, our dedicated and professional staff are here to help you and your family find the best home care available.
Patient Interaction is a Bronx, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Saint Margaret Mercy Healthcare Centers is a Hammond, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.